title: Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.
authors.affiliation: Hematology Department and HCT Unit, G. Papanicolaou Hospital , Thessaloniki , Greece.
authors.forename: Evangelia
authors.initials: E
authors.lastname: Stalika
authors.forename: George
authors.initials: G
authors.lastname: Kanellis
authors.forename: Apostolia
authors.initials: A
authors.lastname: Papalexandri
authors.forename: Michalis
authors.initials: M
authors.lastname: Iskas
authors.forename: Efimia
authors.initials: E
authors.lastname: Vrakidou
authors.forename: Maria
authors.initials: M
authors.lastname: Demonakou
authors.forename: Achilles
authors.initials: A
authors.lastname: Anagnostopoulos
authors.forename: Kostas
authors.initials: K
authors.lastname: Stamatopoulos
authors.forename: Theodora
authors.initials: T
authors.lastname: Papadaki
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D005756:Gastritis / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013274:Stomach Neoplasms / Q000150:complications* / Q000188:drug therapy; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab